Loading clinical trials...
Loading clinical trials...
Patients will be consented and screened within 2 to 6 months of the index ACS. Patients who have elevated depression (BDI\>=15 or BDI\>=10 assessed twice over two week period) and who continue to meet...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Columbia University
Collaborators
NCT07073963 · Sarcoidosis, Fatigue, and more
NCT07329699 · Coronary Artery Disease, Chronic Coronary Syndrome, and more
NCT05883540 · Palliative Care, Pain, and more
NCT06790641 · Perinatal Anxiety, Perinatal Depression, and more
NCT06373718 · Insomnia, Depression
Yale University
New Haven, Connecticut
Emory University
Atlanta, Georgia
Washington University
St Louis, Missouri
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions